Lv1
90 积分 2025-04-28 加入
Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor
5个月前
已完结
Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
5个月前
已完结
Use of pharmacokinetic versus pharmacodynamic endpoints to support human dose predictions: implications for rational drug design and early clinical development
7个月前
已完结
Applications of Model-Based Target Pharmacology Assessment in Defining Drug Design and DMPK Strategies: GSK Experiences
7个月前
已完结
Discovery solubility measurement and assessment of small molecules with drug development in mind
8个月前
已完结
皖公网安备34019202002308
